Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 1/2014

01-02-2014 | Commentary

What is patient adherence? A terminology overview

Authors: Rana Ahmed, Parisa Aslani

Published in: International Journal of Clinical Pharmacy | Issue 1/2014

Login to get access

Abstract

It is well known that patient adherence to appropriately prescribed medications is essential for treatment efficacy and positive therapeutic outcomes. It is also understood that patients who are prescribed medications do not necessarily take them as prescribed. Indeed, variation in patients' medication-taking is an age old conundrum which remains the focus of much interest amongst researchers and clinicians owing to its far-reaching consequences. Despite the extensive adherence-related research over the last four decades and a recent surge in this field, there remains a lack of uniformity in the terminology used to describe adherence and its related concepts. In turn, it is often difficult to conduct comparisons between adherence-related studies, which may be associated with the non-cumulative nature of work in this field. The purpose of this commentary is to provide an overview of key terminology relating to the field of adherence research.
Literature
1.
go back to reference Adams F. Genuine works of Hippocrates. Melbourne: Krieger Publishing; 1972. Adams F. Genuine works of Hippocrates. Melbourne: Krieger Publishing; 1972.
2.
go back to reference World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003. World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003.
3.
go back to reference Fredericks EM, Magee JC, Opipari-Arrigan L, Shieck V, Well A, Lopez MJ. Adherence and health-related quality of life in adolescent liver transplant recipients. Pediatr Transplant. 2008;12(3):289–99.PubMedCrossRef Fredericks EM, Magee JC, Opipari-Arrigan L, Shieck V, Well A, Lopez MJ. Adherence and health-related quality of life in adolescent liver transplant recipients. Pediatr Transplant. 2008;12(3):289–99.PubMedCrossRef
4.
go back to reference Drotar D, Greenley RN, Demeter CA, et al. Adherence to pharmacological treatment for juvenile bipolar disorder. J Am Acad Child Adol Psychiatry. 2007;46(7):831–9.CrossRef Drotar D, Greenley RN, Demeter CA, et al. Adherence to pharmacological treatment for juvenile bipolar disorder. J Am Acad Child Adol Psychiatry. 2007;46(7):831–9.CrossRef
5.
go back to reference Buckley P. Adherence to mental health treatment. New York: Oxford University Press; 2009. Buckley P. Adherence to mental health treatment. New York: Oxford University Press; 2009.
7.
go back to reference Lehane E, Mccarthy G. Medication non-adherence–exploring the conceptual mire. Int J Nurs Pract. 2009;15(1):25–31.PubMedCrossRef Lehane E, Mccarthy G. Medication non-adherence–exploring the conceptual mire. Int J Nurs Pract. 2009;15(1):25–31.PubMedCrossRef
8.
go back to reference Chacko A, Newcorn JH, Feirsen N, Uderman JZ. Improving medication adherence in chronic pediatric health conditions: a focus on ADHD in youth. Curr Pharm Des. 2010;16(22):2416–23.PubMedCrossRef Chacko A, Newcorn JH, Feirsen N, Uderman JZ. Improving medication adherence in chronic pediatric health conditions: a focus on ADHD in youth. Curr Pharm Des. 2010;16(22):2416–23.PubMedCrossRef
9.
go back to reference Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Brit J Clin Pharm. 2012;73(5):691–705.PubMedCrossRef Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Brit J Clin Pharm. 2012;73(5):691–705.PubMedCrossRef
11.
go back to reference Blackburn DF, Swidrovich J, Lemstra M. Non-adherence in type 2 diabetes: practical considerations for interpreting the literature. Patient Prefer Adherence. 2013;7:183–9.PubMedCentralPubMedCrossRef Blackburn DF, Swidrovich J, Lemstra M. Non-adherence in type 2 diabetes: practical considerations for interpreting the literature. Patient Prefer Adherence. 2013;7:183–9.PubMedCentralPubMedCrossRef
12.
go back to reference Sackett DL, Haynes RB. Compliance with therapeutic regimens. Baltimore: The Johns Hopkins University Press; 1976. Sackett DL, Haynes RB. Compliance with therapeutic regimens. Baltimore: The Johns Hopkins University Press; 1976.
13.
go back to reference Hughes CM. Medication non-adherence in the elderly: how big is the problem? Drugs Aging. 2004;21:793–811.PubMedCrossRef Hughes CM. Medication non-adherence in the elderly: how big is the problem? Drugs Aging. 2004;21:793–811.PubMedCrossRef
14.
go back to reference Blackwell B. From compliance to alliance. A quarter century of research. Neth J Med. 1996;48:140–9.PubMed Blackwell B. From compliance to alliance. A quarter century of research. Neth J Med. 1996;48:140–9.PubMed
16.
go back to reference National Heart Foundation of Australia. Improving adherence in cardiovascular care. A toolkit for health professionals. Melbourne: National Heart Foundation of Australia; 2011. National Heart Foundation of Australia. Improving adherence in cardiovascular care. A toolkit for health professionals. Melbourne: National Heart Foundation of Australia; 2011.
17.
go back to reference Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11(1):44–7.PubMedCrossRef Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11(1):44–7.PubMedCrossRef
18.
go back to reference Ascertaining barriers for compliance (ABC) project team. ABC project. [Internet]. [Place unknown]: ABC project; c2010–2012 (2013). Available from: http://abcproject.eu/. Ascertaining barriers for compliance (ABC) project team. ABC project. [Internet]. [Place unknown]: ABC project; c2010–2012 (2013). Available from: http://​abcproject.​eu/​.
19.
go back to reference Caisley H, Muller U. Adherence to medication in adults with attention deficit hyperactivity disorder and pro re nata dosing of psychostimulants: a systematic review. Eur Psychiatry. 2012;27(5):343–9.PubMedCrossRef Caisley H, Muller U. Adherence to medication in adults with attention deficit hyperactivity disorder and pro re nata dosing of psychostimulants: a systematic review. Eur Psychiatry. 2012;27(5):343–9.PubMedCrossRef
20.
go back to reference Nunes V, Neilson J, O’Flynn N, et al. Clinical guidelines and evidence review for medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence. London: National Collaborating Centre for Primary Care and Royal College of General Practitioners; 2009. Nunes V, Neilson J, O’Flynn N, et al. Clinical guidelines and evidence review for medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence. London: National Collaborating Centre for Primary Care and Royal College of General Practitioners; 2009.
21.
go back to reference Robinson JH, Callister LC, Berry JA, Dearing KA. Patient-centered care and adherence: definitions and applications to improve outcomes. J Am Acad Nurs Pract. 2008;20(12):600–7.CrossRef Robinson JH, Callister LC, Berry JA, Dearing KA. Patient-centered care and adherence: definitions and applications to improve outcomes. J Am Acad Nurs Pract. 2008;20(12):600–7.CrossRef
Metadata
Title
What is patient adherence? A terminology overview
Authors
Rana Ahmed
Parisa Aslani
Publication date
01-02-2014
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 1/2014
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-013-9856-y

Other articles of this Issue 1/2014

International Journal of Clinical Pharmacy 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.